The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2353–2376 of 3,535
BioCardia, Inc. has received a positive assessment from Japan’s Pharmaceutical and Medical Device Agency (PMDA) regarding its **CardiAMP® Cell Therapy** for isc...
Boehringer Ingelheim has announced the establishment of a new **AI and machine learning center** in King’s Cross, London, as part of its global Computational In...
**BVI has achieved CE marking for Virtuoso®, the first dual-function phaco-vitrectomy platform, designed to enhance surgical control and efficiency in both cata...
BVI has received CE marking for its **Virtuoso®** platform, the first dual-function phaco-vitrectomy system designed to enhance control, efficiency, and versati...
Tenvie Therapeutics has initiated a Phase 1 clinical trial for **TNV108**, an allosteric inhibitor targeting **SARM1**, aimed at treating **peripheral neuropath...
Artelo Biosciences has published a peer-reviewed article in the *European Journal of Pain* detailing the therapeutic potential of **ART26.12**, a selective inhi...
Psyence Biomedical Ltd. has made significant strides in the **global ibogaine market**, positioning itself as a leader in the development and manufacturing of p...
NewcelX Ltd. has announced a strategic collaboration with Eledon Pharmaceuticals to enhance its flagship Type 1 Diabetes program, NCEL-101. This initiative inte...
BriaCell Therapeutics Corp. has presented promising Phase 3 clinical data demonstrating that their investigational therapy, **Bria-IMT** combined with an immune...
Palvella Therapeutics has announced that clinical results from its Phase 3 SELVA and Phase 2 TOIVA studies of **QTORIN™ 3.9% rapamycin anhydrous gel** will be p...
**Hironori Yamagami, a sleep expert, has identified the FULI Japanese Futon Shikibuton as the top futon mattress for 2026. This product stands out due to its au...
Claire’s Place Foundation is set to host the **12th Annual Glow Ride** on May 9, 2026, at Hermosa Beach Pier, celebrating the resilience of mothers within the c...
Researchers at the University of Lausanne have identified a critical vulnerability in cancer cells related to **vitamin B7 (biotin)**, which acts as a metabolic...
**A recent study utilizing Mendelian randomization has identified potential therapeutic candidates for vascular dementia (VaD), focusing on the effects of 46 ex...
Marc Elia, Chairman of Invivyd, Inc., will address the POLITICO Health Care Summit on April 21, focusing on the **evolving landscape of viral disease prevention...
Pasithea Therapeutics Corp. has announced that the FDA has granted **Rare Pediatric Disease Designation** to its investigational drug, **PAS-004**, aimed at tre...
Conavi Medical Corp. has achieved a significant milestone with the **FDA 510(k) clearance** for its next-generation hybrid imaging system, which integrates **in...
Monte Rosa Therapeutics has unveiled promising preclinical data on its **CCNE1-directed molecular glue degrader (MGD)**, MRT-55811, which shows significant anti...
On April 18, 2026, President Trump signed an Executive Order titled **ACCELERATING MEDICAL TREATMENTS FOR SERIOUS MENTAL ILLNESS**, aimed at expediting research...
**Passage Bio, Inc.** has reported promising interim results from its ongoing Phase 1/2 upliFT-D clinical trial evaluating **PBFT02** for frontotemporal dementi...
Seres Therapeutics has presented compelling data at the 2026 ESCMID congress, showcasing the **Phase 1b study results** of its investigational live biotherapeut...
Soleo Health has launched **SoleoRare**, a dedicated Rare Disease Specialty Pharmacy designed to address the unique needs of patients with rare, ultra-rare, and...
Researchers at Biohub, led by Daniel Zongjie Wang, PhD, and Shana O. Kelley, PhD, have identified a **three-amino acid supplement**—methionine, arginine, and se...
ANI Pharmaceuticals has launched **Pimozide Tablets** in both 1 mg and 2 mg dosages, marking the introduction of a generic version of the reference listed drug...
